Converging molecular pathways in human neural development and degeneration. Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP. Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease? Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Clusterin in cerebrospinal fluid: Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide:
Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.
Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke ISSN: Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: Pashtun Shahim; Niklas Mattsson; E. The zebrafish amyloid precursor protein-b is required for motor neuron guidance and synapse formation. Blomqvist; Emil Egecioglu; Bob Olsson Identification of tissue-specific cell death using methylation patterns of circulating DNA.